Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Deep learning can accurately distinguish dementia from mild cognitive impairment by looking at pictures of analog clocks as drawn by individuals thought to be affected.
AI-aimed blasting of kidney stones from outside the body hit intended targets at a 75% clip in a proof-of-concept study, pulverizing conventional lithotripsy, which missed the mark almost half the time.
The model’s consistent overall accuracy demonstrates the reusability of existing COVID algorithms with recalibrations rather than fallbacks to square one, AI developers suggest.
Medicare is associated with reductions in racial and ethnic disparities in insurance coverage, access to care and self-reported health across the U.S., according to a new study published in JAMA.
Researchers in Denmark and the U.S. have used deep neural networks to develop complementing models for predicting complications likely to arise in patients who’ve had surgeries of all kinds.
When assisted by an AI tool designed to organize and display digitized patient referral records, gastroenterologists cut their time to answer relevant clinical questions by 2.3 minutes.
Beginning around 2031, autonomous virtual assistants will deliver precision preventive medicine while networked provider orgs offer closely connected care via single, shared digital infrastructures.
